COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain

Clara Mazagatos(Instituto de Salud Carlos III), Olalla Vázquez-Cancela(Complejo Hospitalario Universitario de Santiago), Socorro Fernández‐Arribas(Junta de Castilla y León), Jesús Oliva(Instituto de Salud Carlos III), Ana Maribel Martínez(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Eva Martínez Ochoa(Gobierno de La Rioja), Susana Monge(Instituto de Salud Carlos III), Miriam Latorre-Millán(Hospital Universitario Miguel Servet), Silvia Martínez‐Cuenca(Gobierno de Aragón), Bartolomé Sastre‐Palou(Conselleria de Sanitat Universal i Salut Pública), Luca Basile(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Ana Gandarillas(Directorate General of Traffic), Virtudes Gallardo‐García(Junta de Andalucía), Concepción Delgado‐Sanz(Instituto de Salud Carlos III), Francisco Pozo(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Carmen Quiñones‐Rubio(Gobierno de La Rioja), Miriam García‐Vázquez(Gobierno de Aragón), Ana García‐Fulgueiras(Centre for Biomedical Network Research on Rare Diseases), Amelia Fernández‐Sierra(Hospital Universitario Virgen de las Nieves), Mar Rodríguez‐del Águila(Hospital Universitario Virgen de las Nieves), María Isabel Barranco‐Boada(Servicio Murciano de Salud), Ana Milagro(Hospital Universitario Miguel Servet), Olga Hidalgo‐Pardo(Conselleria de Sanitat Universal i Salut Pública), Isabel Losada‐Castillo(Xunta de Galicia), Nicola Lorusso, Cristina Ruiz‐Sopeña(Junta de Castilla y León), María Ordobás(Directorate General of Traffic)
Influenza and Other Respiratory Viruses
July 26, 2022
10.1111/irv.13026
Cited by 12

Related Papers

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021
|Eurosurveillance|2021|281
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Environmental drivers, climate change and emergent diseases transmitted by mosquitoes and their vectors in southern Europe: A systematic review
|Environmental Research|2020|202